Yahoo
OTC Markets OTCPK - Delayed Quote USD

PharmaCielo Ltd. (PCLOF)

0.0400 -0.0010 (-2.44%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for PCLOF
  • Previous Close 0.0410
  • Open 0.0352
  • Bid 0.0351 x 1000000
  • Ask 0.0430 x 4000000
  • Day's Range 0.0352 - 0.0352
  • 52 Week Range 0.0040 - 0.1170
  • Volume 65
  • Avg. Volume 20,248
  • Market Cap (intraday) 8.006M
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date (est.) Nov 26, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. It offers medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. PharmaCielo Ltd. is headquartered in Toronto, Canada.

www.pharmacielo.com

--

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

PCLOF
8.11%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

PCLOF
42.86%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

PCLOF
74.52%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

PCLOF
95.17%
S&P/TSX Composite index (^GSPTSE)
69.32%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY21
Revenue 485.17k
Earnings -8.75M
Profit Margin -1,803.64%

Q4

FY20

Q1

FY21

Q2

FY21

Q3

FY21

-15M
-10M
-5M
0
-2000.0%
-1500.0%
-1000.0%
-500.0%
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -103.08%

  • Return on Assets (ttm)

    -12.67%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    3.6M

  • Net Income Avi to Common (ttm)

    -3.71M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    77.5k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -5.49M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: